Bank of New York Mellon’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.3M Buy
117,616
+28,407
+32% +$4.9M ﹤0.01% 1511
2025
Q1
$13.9M Sell
89,209
-9,183
-9% -$1.43M ﹤0.01% 1690
2024
Q4
$13.5M Sell
98,392
-6,826
-6% -$940K ﹤0.01% 1772
2024
Q3
$15.7M Sell
105,218
-5,423
-5% -$810K ﹤0.01% 1708
2024
Q2
$15.1M Sell
110,641
-40,303
-27% -$5.5M ﹤0.01% 1737
2024
Q1
$22.8M Sell
150,944
-62,225
-29% -$9.41M ﹤0.01% 1500
2023
Q4
$26.8M Sell
213,169
-19,593
-8% -$2.47M 0.01% 1447
2023
Q3
$21.8M Sell
232,762
-83,234
-26% -$7.79M ﹤0.01% 1496
2023
Q2
$28.2M Buy
315,996
+70,577
+29% +$6.3M 0.01% 1361
2023
Q1
$26.3M Sell
245,419
-5,231
-2% -$561K 0.01% 1396
2022
Q4
$30.6M Sell
250,650
-10,791
-4% -$1.32M 0.01% 1303
2022
Q3
$27M Sell
261,441
-8,505
-3% -$878K 0.01% 1318
2022
Q2
$25.1M Sell
269,946
-19,398
-7% -$1.8M 0.01% 1414
2022
Q1
$34M Buy
289,344
+49,298
+21% +$5.79M 0.01% 1355
2021
Q4
$32.3M Sell
240,046
-2,087
-0.9% -$281K 0.01% 1430
2021
Q3
$38.6M Sell
242,133
-20,837
-8% -$3.32M 0.01% 1309
2021
Q2
$34.6M Buy
262,970
+156
+0.1% +$20.5K 0.01% 1414
2021
Q1
$33.9M Buy
262,814
+100,790
+62% +$13M 0.01% 1383
2020
Q4
$27M Buy
162,024
+9,831
+6% +$1.64M 0.01% 1445
2020
Q3
$23.5M Buy
152,193
+15,156
+11% +$2.34M 0.01% 1373
2020
Q2
$20.3M Buy
137,037
+9,820
+8% +$1.45M 0.01% 1433
2020
Q1
$14.3M Sell
127,217
-6,900
-5% -$777K ﹤0.01% 1499
2019
Q4
$18.7M Buy
+134,117
New +$18.7M ﹤0.01% 1612
2019
Q1
Sell
-123,415
Closed -$7.73M 4201
2018
Q4
$7.73M Buy
+123,415
New +$7.73M ﹤0.01% 2056